ENTUVA

Serial Number 87930264
606

Registration Progress

Application Filed
May 21, 2018
Under Examination
Oct 30, 2018
Approved for Publication
Sep 4, 2018
Published for Opposition
Sep 4, 2018
Registered

Trademark Image

ENTUVA

Basic Information

Serial Number
87930264
Filing Date
May 21, 2018
Published for Opposition
September 4, 2018
Abandonment Date
December 2, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 2, 2019
Classes
005

Rights Holder

AMAG Pharmaceuticals, Inc.

03
Address
1100 Winter Street
Waltham, MA 02451

Ownership History

AMAG Pharmaceuticals, Inc.

Original Applicant
03
Waltham, MA

AMAG Pharmaceuticals, Inc.

Owner at Publication
03
Waltham, MA

Legal Representation

Attorney
Jessica S. Parise

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Dec 2, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 2, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Mar 27, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 25, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 25, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 25, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 30, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 4, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 4, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 15, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 25, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 24, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
May 30, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 24, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of sexual dysfunction and sexual disorders; pharmaceutical preparations for sexual dysfunction and sexual disorders, namely, for the treatment of hypoactive sexual desire disorder (HSDD), female sexual dysfunction (FSD) and erectile dysfunction (ED)
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005